Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: A randomized, placebo-controlled study☆☆☆
To access this article, please choose from the options below
☆ The authors who have taken part in the research of this paper declared that they do not have a relationship with the manufacturers of the drug involved either in the past or present and they did not receive funding from the manufacturers to carry out their research. Trial registration number is CCT-NAPN-16065.
☆☆ This study was supported by a grant from the Consejo de Investigación en Salud del Gobierno de la Ciudad de Buenos Aires.
PII: S0168-8278(08)00082-2
doi:10.1016/j.jhep.2008.01.024
© 2008 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
